603716.SHG Wuhan Thalys Med Tech Co Ltd

Healthcare Biotechnology Shanghai Stock Exchange
15.53 CNY
Close of Nov 4, 2026
12.92 31.86
Market cap
CNY 3.51B
P/E
-
P/B
3.17x
ROE
-6.9%
Dividend yield
0.53%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 603716.SHG undervalued?

Graham number

The Graham number of Wuhan Thalys Med Tech Co Ltd cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Wuhan Thalys Med Tech Co Ltd fundamental analysis

No fundamental analysis for Wuhan Thalys Med Tech Co Ltd yet.

Wuhan Thalys Med Tech Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Wuhan Thalys Med Tech Co Ltd

Thalys Medical Technology Group Corporation provides medical integrated operation and management services in China. The company offers fully automated immunofluorescence analyzer; coagulation reagent; COVID-19 test kit; line blot1 fully automated immunoblotting instrument; and flow products. It also provides automated coagulation analyzer; automated immunoassay system; automated biochemical analysis system; automated chemiluminescence immunoassay system; and blood analyzer. …

Full company profile